Emily Durden

590 total citations
25 papers, 455 citations indexed

About

Emily Durden is a scholar working on Epidemiology, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, Emily Durden has authored 25 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Rheumatology and 4 papers in Psychiatry and Mental health. Recurrent topics in Emily Durden's work include Pelvic floor disorders treatments (3 papers), Bipolar Disorder and Treatment (3 papers) and Diabetes Management and Research (3 papers). Emily Durden is often cited by papers focused on Pelvic floor disorders treatments (3 papers), Bipolar Disorder and Treatment (3 papers) and Diabetes Management and Research (3 papers). Emily Durden collaborates with scholars based in United States, Denmark and Germany. Emily Durden's co-authors include Paul Juneau, Lorena López-González, Richard Barron, Lionel Pinto, Robert Fowler, Katherine Gooch, Bong-Chul Chu, David Walker, Rami Ben‐Joseph and Kathleen Wilson and has published in prestigious journals such as The Journal of Urology, Vaccine and Gynecologic Oncology.

In The Last Decade

Emily Durden

25 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Durden United States	12	111	103	97	61	58	25	455
Luiz Francisco Baccaro Brazil	14	96 0.9×	121 1.2×	99 1.0×	56 0.9×	79 1.4×	44	600
Shonda A. Foster United States	18	197 1.8×	138 1.3×	117 1.2×	35 0.6×	59 1.0×	41	782
Kelly Hollis United States	17	269 2.4×	24 0.2×	48 0.5×	50 0.8×	49 0.8×	39	976
Jonathan Aning United Kingdom	15	79 0.7×	18 0.2×	142 1.5×	26 0.4×	52 0.9×	61	745
Jean-Michel Joubert France	12	256 2.3×	27 0.3×	27 0.3×	24 0.4×	15 0.3×	42	472
Joseph M. Gleason United States	14	68 0.6×	16 0.2×	55 0.6×	21 0.3×	58 1.0×	26	515
Charles A. Cefalu United States	13	48 0.4×	95 0.9×	120 1.2×	76 1.2×	53 0.9×	35	557
Nicholas C. Laucis United States	5	50 0.5×	185 1.8×	94 1.0×	70 1.1×	40 0.7×	7	591
Thomas Gray United Kingdom	12	200 1.8×	11 0.1×	47 0.5×	40 0.7×	19 0.3×	57	486
Damir Buković Croatia	14	44 0.4×	13 0.1×	127 1.3×	48 0.8×	51 0.9×	60	570

Countries citing papers authored by Emily Durden

Since Specialization

Citations

This map shows the geographic impact of Emily Durden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Durden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Durden more than expected).

Fields of papers citing papers by Emily Durden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Durden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Durden. The network helps show where Emily Durden may publish in the future.

Co-authorship network of co-authors of Emily Durden

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Durden. A scholar is included among the top collaborators of Emily Durden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Durden. Emily Durden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clarke, Ann E., et al.. (2020). The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States. Seminars in Arthritis and Rheumatism. 50(4). 759–768. 26 indexed citations

Durden, Emily, et al.. (2018). The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age‐related comorbidities in the United States. Neurourology and Urodynamics. 37(5). 1641–1649. 53 indexed citations

Durden, Emily, et al.. (2018). The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States. Journal of Occupational and Environmental Medicine. 60(9). 847–852. 8 indexed citations

Shenolikar, Rahul, Emily Durden, Nicole Meyer, Gregory Lenhart, & Kathleen N. Moore. (2018). Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States. Gynecologic Oncology. 151(2). 190–195. 31 indexed citations

Durden, Emily, et al.. (2017). MP32-03 THE DIRECT AND INDIRECT COSTS DUE TO WORK LOSS ASSOCIATED WITH OVERACTIVE BLADDER IN THE UNITED STATES. The Journal of Urology. 197(4S). 1 indexed citations

Levin, Philip, et al.. (2015). Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidiabetes Drugs. Clinical Therapeutics. 38(1). 110–121. 8 indexed citations

Durden, Emily, Brendan Limone, Paul Juneau, et al.. (2015). Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States. Journal of Managed Care & Specialty Pharmacy. 21(9). 824–833. 41 indexed citations

Ozawa, Sachiko, Lois Privor-Dumm, Emily Durden, et al.. (2014). Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: Literature vs. policymakers’ beliefs. Vaccine. 32(32). 4089–4096. 7 indexed citations

Narayanan, S, et al.. (2013). Economic Burden of Systemic Lupus Erythematosus Flares and Comorbidities in a Commercially Insured Population in the United States. Journal of Occupational and Environmental Medicine. 55(11). 1262–1270. 37 indexed citations

10.

Oglesby, AK, Emily Durden, S Narayanan, Paul Juneau, & Kathleen Wilson. (2013). Economic burden of systemic lupus erythematosus (SLE) in a commercially insured population in the United States. Value in Health. 16(3). A126–A126. 2 indexed citations

11.

Shi, Nianwen, et al.. (2012). Healthcare utilization among patients with depression before and after initiating duloxetine in the United Kingdom. Journal of Medical Economics. 15(4). 672–680. 3 indexed citations

12.

Bagalman, Erin, Erik Muser, Jiyoon Choi, et al.. (2011). Health Care Resource Utilization and Costs in a Commercially Insured Population of Patients With Bipolar Disorder Type I and Frequent Psychiatric Interventions. Clinical Therapeutics. 33(10). 1381–1390.e4. 12 indexed citations

13.

Cao, Zhun, Kelly H. Zou, Christine L. Baker, et al.. (2011). Respiratory-related medical expenditure and inpatient utilisation among COPD patients receiving long-acting bronchodilator therapy. Journal of Medical Economics. 14(2). 147–158. 4 indexed citations

14.

Fairchild, Carol, et al.. (2011). Outcomes and Cost Comparison of Three Therapeutic Approaches to Allergic Rhinitis. American Journal of Rhinology and Allergy. 25(4). 257–262. 6 indexed citations

15.

Knight, Tyler, et al.. (2010). Clinical and Economic Outcomes in Medicare Beneficiaries with Stage 3 or Stage 4 Chronic Kidney Disease and Anemia: The Role of Intravenous Iron Therapy. Journal of Managed Care Pharmacy. 16(8). 605–615. 10 indexed citations

16.

Khoury, Antoine C. El, Emily Durden, Larry Ma, et al.. (2010). Perception and management of fever in infants up to six months of age: A survey of US pediatricians. BMC Pediatrics. 10(1). 95–95. 6 indexed citations

17.

Durden, Emily, Erin Bagalman, Erik Muser, et al.. (2010). Characteristics, healthcare utilization and costs of bipolar disorder type I patients with and without frequent psychiatric intervention in a Medicaid population. Journal of Medical Economics. 13(4). 698–704. 9 indexed citations

18.

Bagalman, Erin, Kristina Yu-Isenberg, Emily Durden, et al.. (2010). Indirect Costs Associated With Nonadherence to Treatment for Bipolar Disorder. Journal of Occupational and Environmental Medicine. 52(5). 478–485. 21 indexed citations

19.

Durden, Emily, Berhanu Alemayehu, Jonathan Bouchard, Bong-Chul Chu, & Mark Aagren. (2009). Direct Health Care Costs of Patients With Type 2 Diabetes Within a Privately Insured Employed Population, 2000 and 2005. Journal of Occupational and Environmental Medicine. 51(12). 1460–1465. 14 indexed citations

20.

Durden, Emily, et al.. (2008). Economic Costs of Obesity to Self-Insured Employers. Journal of Occupational and Environmental Medicine. 50(9). 991–997. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact